ct26 cells (Genecopoeia)
Structured Review

Ct26 Cells, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/single+cell+expression+data/Mouse+cell+line+CT26+stably+expressing+Cas9%2C+randomly+inserted%2C+single+clone/pmc05979455-161-0-19
Average 94 stars, based on 12 article reviews
Images
1) Product Images from "Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging"
Article Title: Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging
Journal: International Journal of Molecular Sciences
doi: 10.3390/ijms19041002
Figure Legend Snippet: Bystander effect of MSC-Tet-TK and MSC-TK cells. ( A ) Rluc activity in co-cultures (1:1) of naive MSCs and CT26/Rluc cells treated with the indicated concentrations of GCV for 48 h. ( B ) BLI images of the Rluc activity and quantitation data of CT26/Rluc in co-cultures (1:1) of MSC-TK or MSC-Tet-TK cells in the absence or presence of doxycycline (DOX(−) and DOX 2 μg/mL respectively). Three individual experiment values are expressed as the mean ± standard deviation (SD), * p < 0.05, ** p < 0.01, *** p < 0.001 (by Student’s t test). p/s, photons/second.
Techniques Used: Activity Assay, Quantitation Assay, Standard Deviation
Figure Legend Snippet: In vivo therapeutic effect of MSC-Tet-TK and MSC-TK cells on inhibiting colon tumor growth. ( A ) Renilla luciferase (Rluc) imaging of colon cancer cells (CT26/Rluc) in mice treated with either MSC-TK or MSC-Tet-TK cells with or without concurrent GCV treatment. BLI images were taken on days 0, 6, and 13 in five individual mice; ( B ) Quantitative analysis of the data shown in ( A ). ( C ) Tumor weights assessed at study end. Bioluminescence activity is shown in photons/second (p/s). * p < 0.05 compared separately to MSC-Tet-TK (GCV−) and MSC-TK (GCV−).
Techniques Used: In Vivo, Luciferase, Imaging, Activity Assay
Related Articles
Infection:Article Title: Enhanced Apc Min/+ adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells. Article Snippet: The antibodies used for ChIP included CUL4B (Sigma-Aldrich Cat# C9995, RRID: AB_1840781), EZH2 (Cell Signaling Technology, Cat# 5246S), H2AK119ub1 (Cell Signaling Technology, Cat# 8240S) and H3K27me3 (Cell Signaling Technology, Cat# 9733S). .. Cell lines culture and viral infection HCT116 and Article Title: Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model Article Snippet: .. To create Article Title: Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model. Article Snippet: .. To create Expressing:Article Title: E-selectin-targeted polymer-doxorubicin conjugate induces regression of established colorectal liver metastases and improves mice survival Article Snippet: Liver metastases arising from colorectal cancer (CRC) are a major challenge for cancer treatment, as they often emerge as unresectable and resistant to therapy.. Novel treatments targeting the specific metastatic tumor microenvironment (TME) may improve the therapeutic outcome.. One relevant receptor at the TME in the liver is the endothelial-expressed cell adhesion molecule E-selectin. Luciferase:Article Title: E-selectin-targeted polymer-doxorubicin conjugate induces regression of established colorectal liver metastases and improves mice survival Article Snippet: Liver metastases arising from colorectal cancer (CRC) are a major challenge for cancer treatment, as they often emerge as unresectable and resistant to therapy.. Novel treatments targeting the specific metastatic tumor microenvironment (TME) may improve the therapeutic outcome.. One relevant receptor at the TME in the liver is the endothelial-expressed cell adhesion molecule E-selectin. Incubation:Article Title: Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model Article Snippet: .. To create Article Title: Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model. Article Snippet: .. To create Injection:Article Title: Inducible CCR2 + nonclassical monocytes mediate the regression of cancer metastasis Article Snippet: The TLR7/8 agonist R848 (vac-r848, Invitrogen), Notch signaling inhibitors DAPT (208255-80-5, Cayman Chemical) and gliotoxin (G9893, MilliporeSigma), and LPS (L2630, MilliporeSigma) were administered to mice by i.v. injection at doses of 50 μg/mouse, 25 mg/kg and 10 mg/kg, and 1 μg/mouse, respectively. .. 3 × 10 5 (or the indicated number of cells) B16F10-LUC2 (catalog CRL-6475-LUC2, ATCC), B16F10-EGFP (CL053-STAN, Imanis Life Science), 4T1-LUC2-GFP or Article Title: Inducible CCR2+ nonclassical monocytes mediate the regression of cancer metastasis Article Snippet: The TLR7/8 agonist R848 (vac-r848, Invitrogen), Notch signaling inhibitors DAPT (208255-80-5, Cayman Chemical) and gliotoxin (G9893, MilliporeSigma), and LPS (L2630, MilliporeSigma) were administered to mice by i.v. injection at doses of 50 μg/mouse, 25 mg/kg and 10 mg/kg, and 1 μg/mouse, respectively. .. 3 × 105 (or the indicated number of cells) B16F10-LUC2 (catalog CRL-6475-LUC2, ATCC), B16F10-EGFP (CL053-STAN, Imanis Life Science), 4T1-LUC2-GFP or Isolation:Article Title: Inducible CCR2+ nonclassical monocytes mediate the regression of cancer metastasis Article Snippet: The TLR7/8 agonist R848 (vac-r848, Invitrogen), Notch signaling inhibitors DAPT (208255-80-5, Cayman Chemical) and gliotoxin (G9893, MilliporeSigma), and LPS (L2630, MilliporeSigma) were administered to mice by i.v. injection at doses of 50 μg/mouse, 25 mg/kg and 10 mg/kg, and 1 μg/mouse, respectively. .. 3 × 105 (or the indicated number of cells) B16F10-LUC2 (catalog CRL-6475-LUC2, ATCC), B16F10-EGFP (CL053-STAN, Imanis Life Science), 4T1-LUC2-GFP or Real-time Polymerase Chain Reaction:Article Title: Inducible CCR2+ nonclassical monocytes mediate the regression of cancer metastasis Article Snippet: The TLR7/8 agonist R848 (vac-r848, Invitrogen), Notch signaling inhibitors DAPT (208255-80-5, Cayman Chemical) and gliotoxin (G9893, MilliporeSigma), and LPS (L2630, MilliporeSigma) were administered to mice by i.v. injection at doses of 50 μg/mouse, 25 mg/kg and 10 mg/kg, and 1 μg/mouse, respectively. .. 3 × 105 (or the indicated number of cells) B16F10-LUC2 (catalog CRL-6475-LUC2, ATCC), B16F10-EGFP (CL053-STAN, Imanis Life Science), 4T1-LUC2-GFP or cDNA Synthesis:Article Title: Inducible CCR2+ nonclassical monocytes mediate the regression of cancer metastasis Article Snippet: The TLR7/8 agonist R848 (vac-r848, Invitrogen), Notch signaling inhibitors DAPT (208255-80-5, Cayman Chemical) and gliotoxin (G9893, MilliporeSigma), and LPS (L2630, MilliporeSigma) were administered to mice by i.v. injection at doses of 50 μg/mouse, 25 mg/kg and 10 mg/kg, and 1 μg/mouse, respectively. .. 3 × 105 (or the indicated number of cells) B16F10-LUC2 (catalog CRL-6475-LUC2, ATCC), B16F10-EGFP (CL053-STAN, Imanis Life Science), 4T1-LUC2-GFP or |

